Author Login IJIRT Partner Network (IPN) Login

Formulation and evaluation of captopril transdermal liposomsal gel

  • Unique Paper ID: 157905
  • Volume: 9
  • Issue: 8
  • PageNo: 219-236
  • Abstract:
  • In the present study, Captopril liposomsal gel were developed in order to accomplish short half life of captopril to eliminated a first-pass metabolism of captopril in GIT. To enhances the bio-availability of drug. To increases a sustained release of drug for prolonged period of time. Firstly, developed liposomes by ether injection method and then formulated a liposomal gel by using dispersion method. For this purpose, Phospholipon-90H, cholesterol and stearylamine was chosen as excipient for formulated a liposomes. By taken different concentration of stearylamine and cholesterol applied a full factorial design. All the nine batches were evaluated with respect to the drug content and entrapment efficiency, in-vitro drug diffusion. The optimized batches were evaluated with respect to particle size, FESEM, FTIR and zeta potential. The in vitro drug released of liposomes was found to be 45.48±0.36% at 10 hrs and 54.84±2.63% up to 12 hours respectively, followed super case II transport mechanism with zero order release. The results of in-vitro revealed that captopril liposomes gives a sustained released as compared to captopril solution. The optimized sustained release batch was used to formulate captopril liposomal gel. The 1% liposomal gel was evaluated with respect to the spreadability, viscosity, drug content, ph measurement and in vitro diffusion study. Into in vitro diffusion studied data of captopril liposomal gel compared with captopril gel which showed that liposomal gel gives sustained release of drug 45.18±0.51% up to 12 hrs. Captopril gel formulation used transdermally to treat a hypertension. Also, eliminated a problem of orally administered drug caused. It also protects a drug from hepatic degradation. Increase better patient compliances.
Download article email to a friend

Cite This Article

  • ISSN: 2349-6002
  • Volume: 9
  • Issue: 8
  • PageNo: 219-236

Formulation and evaluation of captopril transdermal liposomsal gel

Related Articles

Impact Factor
8.01 (Year 2024)
UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now

Latest Publication

Archive

View More

Recent Conferences

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024

Submit inquiry